BTG 1501
Alternative Names: SC 48274Latest Information Update: 23 May 1995
At a glance
- Originator Unknown
- Developer Pharmacia Corporation
- Class Antidepressants; Anxiolytics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 23 May 1995 Discontinued-II for Anxiety disorders in USA (PO)